Purchases and Sales Made in Q3 2022 in Vanda Pharmaceuticals Inc. (VNDA)
This table provides information about the institutional ownership of Vanda Pharmaceuticals Inc. (VNDA) during Q3 2022. The information is specifically focused on institutions that hold shares of Vanda Pharmaceuticals Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 15, 2022
Q3 2022
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
SELL
|
- |
-176K- 17.02% |
$1.66M - $2.06M
|
856K
$4.23M
|
|
|
Nov 14, 2022
Q3 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-185K- 27.41% |
$1.74M - $2.17M
|
489K
$2.42M
|
|
|
Nov 14, 2022
Q3 2022
|
Palo Alto Investors LP
Palo Alto, CA |
SELL
|
- |
-325K- 13.05% |
$3.07M - $3.82M
|
2.17M
$10.7M
|
|
|
Nov 14, 2022
Q3 2022
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-341K- 9.38% |
$3.22M - $4.01M
|
3.3M
$16.3M
|
|
|
Oct 27, 2022
Q3 2022
|
Assenagon Asset Management S.A.
|
SELL
|
- |
-937K- 37.07% |
$8.84M - $11M
|
1.59M
$7.85M
|
|
|
Nov 14, 2022
Q3 2022
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-1.04M- 87.4% |
$9.82M - $12.2M
|
150K
$741K
|